ID
18454
Beschrijving
Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2; ODM derived from: https://clinicaltrials.gov/show/NCT00085839
Link
https://clinicaltrials.gov/show/NCT00085839
Trefwoorden
Versies (1)
- 06-11-16 06-11-16 -
Geüploaded op
6 november 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Non-Small Cell Lung Cancer NCT00085839
Eligibility Non-Small Cell Lung Cancer NCT00085839
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Abnormality of the gastrointestinal tract
Datatype
boolean
Alias
- UMLS CUI [1]
- C4023588
Beschrijving
cancer treatment
Datatype
boolean
Alias
- UMLS CUI [1]
- C0920425
Beschrijving
Epidermal growth factor receptor inhibitor
Datatype
boolean
Alias
- UMLS CUI [1]
- C1443775
Beschrijving
Malignant Neoplasms
Datatype
boolean
Alias
- UMLS CUI [1]
- C0006826
Beschrijving
Metastatic malignant neoplasm to brain Uncontrolled
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0220650
- UMLS CUI [1,2]
- C0205318
Beschrijving
Abnormality of the cornea Severe
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1855670
- UMLS CUI [1,2]
- C0205082
Beschrijving
Heart Disease Significant
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0018799
- UMLS CUI [1,2]
- C0750502
Similar models
Eligibility Non-Small Cell Lung Cancer NCT00085839
- StudyEvent: Eligibility
C3258246 (UMLS CUI [2])
C0205210 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C0205483 (UMLS CUI [2,2])
C0205318 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,2])